Feb
Are You Prepared To Face The Patent Office As It Is Going To Grant Only Narrow Patents?
Chemical and pharmaceutical companies protect their investment in research and development and the future of the companies by securing patents on their inventions. Success or failure of the company often depends on the strength of the patent or in its ability to resist competition.
Recently, the United States Patent and Trademark Office proposed changes to the way patents will be processed with a view to reduce patent Examiner’s work load. These changes could drastically limit the company’s ability to secure strong patents. Under the current practice, if the company is not happy with the Examiner’s refusal to grant a patent, the company can file one, two, or more continuation patent applications so that additional exchanges can take place between the applicant and the Examiner.

